Chiron Investment Management, LLC Dexcom Inc Transaction History

Chiron Investment Management, LLC

  • $281 Million
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$112.47 - $130.98 $281,962 - $328,366
-2,507 Reduced 35.17%
4,621 $593,000
Q1 2023

May 15, 2023
BUY
$104.0 - $122.92 $595,400 - $703,717
5,725 Added 408.05%
7,128 $828,000
Q4 2022

Feb 13, 2023
SELL
$84.98 - $122.67 $59,231 - $85,500
-697 Reduced 33.19%
1,403 $158,000
Q3 2022

Nov 14, 2022
BUY
$76.35 - $94.18 $160,335 - $197,778
2,100 New
2,100 $169,000
Q1 2022

May 13, 2022
SELL
$94.08 - $130.2 $99,536 - $137,751
-1,058 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$129.87 - $162.82 $137,402 - $172,263
1,058 New
1,058 $568,000

Others Institutions Holding DXCM

# of Institutions
1,014
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Chiron Investment Management, LLC Portfolio

Follow Chiron Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chiron Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chiron Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email